Misonix Announces Product Accepted for Use in Evidence and Anthrax Protection.Business Editors/Health & Medical Writers FARMINGDALE, N.Y.--(BW HealthWire)--Nov. 5, 2001 Misonix, Inc. (Nasdaq:MSON MSON Multi-Service Optical Networking (SBC) MSON Medium Speed on ) today announced that there has been a substantial increase in the application and sales of Ductless Fume fume Occupational medicine A solid suspension resulting from condensation of the products of combustion. See Inhalant Vox populi verbTo be in the midst of a mental mini-meltdown. Enclosures. These systems, which can be applied for mailroom, evidence and forensic protection, have gained acceptance as an effective form of protection from unknown materials, such as Anthrax. The Company has experienced a significant increase in sales and requests for proposals by prospective clients as companies and governmental agencies are on heightened alert due to the threat of bio-terrorism. Misonix's Ductless Fume Enclosures are recommended to protect workers. In addition, orders for Chemical Work Stations and Forensic Evidence Cabinets are being met to aid in the recovery of the overwhelming amount of evidence collected at the World Trade Center disaster site. "Recently, we had our own scare with a suspicious letter; however, our employees felt safe opening it under one of our Ductless Fume Enclosures. I believe everyone should offer their employees this same level of protection," said Michael McManus, President and Chief Executive Officer of Misonix. "With the heightened security and increased precautions taken to protect federal and local government workers, we have seen an even greater level of interest, especially in our mail handling stations. Misonix is proud to be part of the countrywide effort." The Ductless Fume Enclosures protect workers from chemicals, fumes and odors with activated carbon filters. Our Carbon filters can be designed to remove war gases and are available for manufacture to military specifications. Additional filters protect workers from exposure to possible powder and particulate hazards. Typical biological bacterial spores range in size from 0.5 to 5 microns in size. Electrostatically charged fiber prefilters remove sub-micron particles down to 0.5 microns. HEPA HEPA abbr. 1. high-efficiency particulate air 2. high-efficiency particulate arresting (High Efficiency Particulate Air) Filters have an efficiency rating of 99.997% for collecting particles down to 0.3 microns. ULPA ULPA Ultra Low Penetration Air (filter) ULPA Uniform Limited Partnership Act ULPA Ultra HEPA ULPA United Lightning Protection Association ULPA Ultra Pure Air ULPA Ultra Light Particle Arrester (Ultra Low Penetration Air) filters are efficient to 99.99996% and are available for filtering particles down to 0.12 microns. Misonix Ductless Fume Hoods are typically configured to include filters to meet specific applications. Misonix's PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) Laminar Flow Preparation Stations are used to prepare sterile samples without the risk of contamination when working with DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. and RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic to identify the genetic material of any specific bacteria present. Misonix, Inc. develops, manufactures, and/or markets medical, scientific, and industrial ultrasonic and air pollution systems, and maintains a minority equity position in Focus Surgery as its exclusive manufacturer of the Sonablate(TM) system. Forward Looking Statements: Statements in this news release looking forward in time are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that forward-looking statements involve risks and uncertainties, including general economic conditions, delays and risks associated with the performance of contracts, uncertainties as a result of research and development, potential acquisitions, consumer and industry acceptance, litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. and/or court proceedings, and regulatory risks including approval of pending and/or contemplated 510K filings. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion